542 related articles for article (PubMed ID: 29155882)
21. Identification of novel quinazolinedione derivatives as RORγt inverse agonist.
Fukase Y; Sato A; Tomata Y; Ochida A; Kono M; Yonemori K; Koga K; Okui T; Yamasaki M; Fujitani Y; Nakagawa H; Koyama R; Nakayama M; Skene R; Sang BC; Hoffman I; Shirai J; Yamamoto S
Bioorg Med Chem; 2018 Feb; 26(3):721-736. PubMed ID: 29342416
[TBL] [Abstract][Full Text] [Related]
22. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway.
Su CC; Lin HC; Lin YP; Shan YS; Yang BC
Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists.
Hintermann S; Guntermann C; Mattes H; Carcache DA; Wagner J; Vulpetti A; Billich A; Dawson J; Kaupmann K; Kallen J; Stringer R; Orain D
ChemMedChem; 2016 Dec; 11(24):2640-2648. PubMed ID: 27902884
[TBL] [Abstract][Full Text] [Related]
24. Post-translational regulation of RORγt-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases.
Rutz S; Eidenschenk C; Kiefer JR; Ouyang W
Cytokine Growth Factor Rev; 2016 Aug; 30():1-17. PubMed ID: 27481185
[TBL] [Abstract][Full Text] [Related]
25. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
[TBL] [Abstract][Full Text] [Related]
26. Foxo1 Is a T Cell-Intrinsic Inhibitor of the RORγt-Th17 Program.
Lainé A; Martin B; Luka M; Mir L; Auffray C; Lucas B; Bismuth G; Charvet C
J Immunol; 2015 Aug; 195(4):1791-803. PubMed ID: 26170390
[TBL] [Abstract][Full Text] [Related]
27. Reciprocal regulation of RORγt acetylation and function by p300 and HDAC1.
Wu Q; Nie J; Gao Y; Xu P; Sun Q; Yang J; Han L; Chen Z; Wang X; Lv L; Tsun A; Shen J; Li B
Sci Rep; 2015 Nov; 5():16355. PubMed ID: 26549310
[TBL] [Abstract][Full Text] [Related]
28. siRNA‑mediated knockdown of T‑bet and RORγt contributes to decreased inflammation in pre‑eclampsia.
Wang J; Wen ZQ; Cheng XY; Mei TY; Chen ZF; Su LX
Mol Med Rep; 2017 Nov; 16(5):6368-6375. PubMed ID: 28849203
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (RORγt) inhibitor, S18-000003.
Sasaki Y; Odan M; Yamamoto S; Kida S; Ueyama A; Shimizu M; Haruna T; Watanabe A; Okuno T
Bioorg Med Chem Lett; 2018 Dec; 28(22):3549-3553. PubMed ID: 30301676
[TBL] [Abstract][Full Text] [Related]
30. 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivative attenuates lupus nephritis with less effect to thymocyte development.
Wei F; Zhou X; Chen H; Tian X; Liu Z; Yu B; He X; Bai C; Huang Z
Immunol Res; 2021 Aug; 69(4):378-390. PubMed ID: 34219199
[TBL] [Abstract][Full Text] [Related]
31. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
32. The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT.
Karaś K; Sałkowska A; Karwaciak I; Walczak-Drzewiecka A; Dastych J; Bachorz RA; Ratajewski M
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744223
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
Fasching P; Stradner M; Graninger W; Dejaco C; Fessler J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098832
[TBL] [Abstract][Full Text] [Related]
34. Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.
Kojima H; Takeda Y; Muromoto R; Takahashi M; Hirao T; Takeuchi S; Jetten AM; Matsuda T
Toxicology; 2015 Mar; 329():32-9. PubMed ID: 25583575
[TBL] [Abstract][Full Text] [Related]
35. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.
Solt LA; Kumar N; Nuhant P; Wang Y; Lauer JL; Liu J; Istrate MA; Kamenecka TM; Roush WR; Vidović D; Schürer SC; Xu J; Wagoner G; Drew PD; Griffin PR; Burris TP
Nature; 2011 Apr; 472(7344):491-4. PubMed ID: 21499262
[TBL] [Abstract][Full Text] [Related]
36. A novel isoform of the orphan receptor RORγt suppresses IL-17 production in human T cells.
Rauen T; Juang YT; Hedrich CM; Kis-Toth K; Tsokos GC
Genes Immun; 2012 Jun; 13(4):346-50. PubMed ID: 22237416
[TBL] [Abstract][Full Text] [Related]
37. p300 promotes differentiation of Th17 cells via positive regulation of the nuclear transcription factor RORγt in acute respiratory distress syndrome.
Chen Y; Wang D; Zhao Y; Huang B; Cao H; Qi D
Immunol Lett; 2018 Oct; 202():8-15. PubMed ID: 30009847
[TBL] [Abstract][Full Text] [Related]
38. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress modulates the cytokine response of differentiated Th17 and Th1 cells.
Abimannan T; Peroumal D; Parida JR; Barik PK; Padhan P; Devadas S
Free Radic Biol Med; 2016 Oct; 99():352-363. PubMed ID: 27567538
[TBL] [Abstract][Full Text] [Related]
40. Th17 cells and their cytokines serve as potential therapeutic target in experimental autoimmune neuritis.
Liu S; Liu Y; Xiao Z; Pan S; Gong Q; Lu Z
Brain Behav; 2019 Dec; 9(12):e01478. PubMed ID: 31742934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
